Fluidigm Co. (NASDAQ:FLDM) traded down 3.7% during mid-day trading on Wednesday . The company traded as low as $9.69 and last traded at $9.71, with a volume of 136,306 shares changing hands. The stock had previously closed at $10.08.

A number of equities research analysts recently issued reports on the stock. Cantor Fitzgerald reissued a “buy” rating and issued a $13.00 price objective on shares of Fluidigm in a report on Thursday, June 2nd. Zacks Investment Research lowered shares of Fluidigm from a “buy” rating to a “hold” rating in a report on Monday. Deutsche Bank AG assumed coverage on shares of Fluidigm in a report on Wednesday, June 1st. They issued a “buy” rating for the company. Leerink Swann dropped their price objective on shares of Fluidigm from $20.00 to $15.00 and set an “outperform” rating for the company in a report on Tuesday, April 12th. Finally, Mizuho dropped their price objective on shares of Fluidigm from $11.00 to $8.00 and set a “buy” rating for the company in a report on Thursday, May 5th. Five analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $13.74.

The stock has a 50 day moving average of $9.76 and a 200 day moving average of $8.47. The firm’s market cap is $280.88 million.

Fluidigm (NASDAQ:FLDM) last announced its earnings results on Thursday, May 5th. The company reported ($0.40) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.53) by $0.13. The business earned $29 million during the quarter, compared to analyst estimates of $26.95 million. During the same period in the previous year, the company earned ($0.25) earnings per share. The business’s revenue for the quarter was up 8.6% on a year-over-year basis. Equities analysts expect that Fluidigm Co. will post ($2.23) EPS for the current fiscal year.

Several institutional investors have made changes to their positions in the stock. Columbia Wanger Asset Management LLC acquired a new position in shares of Fluidigm during the fourth quarter worth about $19,337,000. Neuberger Berman Group LLC raised its stake in Fluidigm by 38.1% in the fourth quarter. Neuberger Berman Group LLC now owns 572,319 shares of the company’s stock valued at $6,187,000 after buying an additional 157,760 shares in the last quarter. Finally, Marshall Wace LLP purchased a new stake in Fluidigm during the fourth quarter valued at about $1,045,000.

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.